Answers are grounded in this paper and cite their sources.
Palmoplantar psoriasis (PP), palmoplantar pustulosis (PPP) and hyperkeratotic palmoplantar eczema (HPE) are acral inflammatory skin diseases with overlapping clinical manifestations, complicating diagnosis and treatment. Histopathology and dermoscopy may aid differentiation, but uncertainty persists, and comparative molecular data remain limited. This scoping review aimed to describe the literature on clinical, dermoscopy, histopathological and molecular differences among patients with PP, PPP and HPE. PubMed, Embase and Web of Science were searched until October 2025. Eligible studies compared at least 2 of the diseases. Two reviewers screened the articles. Twenty-five studies were identified, comprising 1,621 patients, mainly about PP and HPE. Clinical findings overlapped. However, nail involvement supported PP, pustules and female predominance characterized PPP, and palmar involvement favoured HPE. Dermoscopy showed potentially distinguishing patterns, with regular vessels, white scales and a red background in PP vs irregular vessels, yellow scaling and a yellowdull-red background in HPE, with no studies on PPP. Histopathology suggested potential differentiators: PP showed psoriasiform changes, HPE spongiosis and PPP intraepidermal pustules. Molecular studies suggested T helper 1 (Th1)/interleukin-17 signatures in PP, neutrophil-driven responses in PPP and a Th2-Th1 profile in HPE. This scoping review aimed to describe the literature on clinical, dermoscopy, histopathological and molecular differences among patients with PP, PPP and HPE.
No takes yet. Share an insight, caveat, or question.
Johansen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: